Clinical Trials on Moderate and Severe Plaque Psoriasis in Singapore

Total 53 results

Novartis Pharmaceuticals

Completed

Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens (SCULPTURE)

Moderate to Severe Plaque-type Psoriasis

United States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
Novartis Pharmaceuticals

Completed

4 Year Extension Study of Efficacy and Safety of Secukinumab in Patients With Moderate to Severe Chronic Plaque-type Psoriasis

Moderate to Severe Chronic Plaque-Type Psoriasis

United States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
Novartis Pharmaceuticals

Completed

Extension Study of Secukinumab Prefilled Syringes in Subjects With Moderate to Severe Chronic Plaque-type Psoriasis Completing Preceding Psoriasis Phase III Studies With Secukinumab

Moderate to Severe Plaque-type Psoriasis

Germany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
Singapore General Hospital
Translational Immunology Institute

Recruiting

Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis

Plaque Psoriasis

Singapore
Singapore General Hospital
Translational Immunology Institute

Not yet recruiting

Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque Psoriasis

Plaque Psoriasis

Singapore
Johnson & Johnson Pte Ltd

Completed

A Study to Evaluate Ustekinumab in Patients With Plaque Psoriasis in Asia-Pacific Countries (MARCOPOLO)

Plaque Psoriasis

Taiwan, Korea, Republic of, Malaysia, Singapore, Indonesia
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule

Dengue Fever | Dengue Hemorrhagic Fever

Singapore
Sanofi Pasteur, a Sanofi Company

Completed

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Singapore
Novartis

Completed

Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension

Moderate to Severe Hypertension

Russian Federation, Romania, Singapore, Spain, Germany, Philippines
National University Hospital, Singapore
Tan Tock Seng Hospital; Ng Teng Fong General Hospital

Completed

Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore

Dengue Hemorrhagic Fever | Severe Dengue | Dengue Shock Syndrome

Singapore
National University Hospital, Singapore

Completed

The Effect of A Dental Application to Promote Self-Administered Plaque Control: A RCT

Periodontitis | Gingivitis | Plaque, Dental

Singapore
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis (FIXTURE)

Chronic Plaque Psoriasis

Germany, United States, Colombia, Italy, Spain, Belgium, Egypt, Hungary, Australia, Singapore, France, Sweden, Guatemala, Philippines, Korea, Republic of, United Kingdom, Argentina, Poland, Romania, Canada, Iceland, India, Finland
Groupe Hospitalier Pitie-Salpetriere

Completed

Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective. (ReFlaP)

Psoriatic Arthritis

United States, Austria, Brazil, Canada, Estonia, France, Germany, Italy, Romania, Russian Federation, Singapore, Spain, Turkey, United Kingdom
Tysana Pte Ltd

Completed

Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans

Treatment of Acute Yellow Fever Virus Infection

Singapore
National University Hospital, Singapore

Recruiting

The Immediate Effectiveness of a 3D Intraoral Scanner as an Oral Hygiene Educational Tool (3D scanner)

Periodontal Diseases | Plaque Induced Gingival Disease

Singapore
Singapore General Hospital
Duke-NUS Graduate Medical School; 60 Degrees Pharmaceuticals LLC

Withdrawn

Celgosivir or Modipafant as Treatment for Adult Participants With Uncomplicated Dengue Fever in Singapore

Dengue Fever

Singapore
Singapore General Hospital
Duke-NUS Graduate Medical School

Completed

Celgosivir as a Treatment Against Dengue (CELADEN)

Dengue Fever

Singapore
Singapore General Hospital

Completed

Yellow Fever Vaccine on Statin/ Non Statin Subjects

Yellow Fever | Yellow Fever Vaccine

Singapore
Paracrine Therapeutics Dermatology Pte. Ltd.
National University Hospital, Singapore

Completed

Safety and Tolerability Study of MSC Exosome Ointment

Psoriasis

Singapore
Institute of Bioengineering and Bioimaging (IBB)
National Skin Centre, Singapore

Recruiting

Non-invasive Photoacoustic Imaging of Skin Inflammatory Disorders With Machine Learning-assisted Scoring

Psoriasis | Eczema

Singapore
Janssen Research & Development, LLC

Terminated

A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever

Dengue

Singapore
Takeda

Completed

Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore

Dengue Fever

Singapore
Changi General Hospital
Singhealth Foundation

Completed

Glutamine Supplementation in Critically Ill Patients With Severe Sepsis (CGH-GLU)

Severe Sepsis

Singapore
National University Hospital, Singapore
Singapore General Hospital; Duke-NUS Graduate Medical School

Unknown

Ketotifen as a Treatment for Vascular Leakage During Dengue Fever (KETODEN)

Dengue Fever | Pleural Effusion

Singapore
Danone Nutricia Research

Terminated

An Exploratory Study to Compare the Differences in Nutritional Status Between Patients With Mild and Moderate Alzheimer's Disease (AD) and Cognitively Intact Healthy People in an Asian Population

Mild and Moderate Alzheimer's Disease | Cognitively Healthy People

Singapore
University Hospital, Basel, Switzerland
Boehringer Ingelheim

Recruiting

International Rare And Severe Psoriasis Expert Network (IRASPEN)

Pustular Psoriasis (PP)

Germany, Italy, Singapore, Switzerland, Portugal, Turkey
Singapore General Hospital
Duke-NUS Graduate Medical School

Completed

The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans

Encephalitis, Japanese | Yellow Fever

Singapore
National University Health System, Singapore

Completed

Dental Implant Care and Oral Hygiene Practices

Peri-Implantitis | Dental Plaque | Peri-implant Mucositis

Singapore
Singapore Eye Research Institute

Unknown

Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty (TE-EK)

Fuchs' Endothelial Dystrophy | Bullous Keratopathy | Mild to Moderate Corneal Endothelial Decompensation | Post-surgical Corneal Decompensation (Irreversible)

Singapore
Tan Tock Seng Hospital
National University Hospital, Singapore; University of Malaya; Singapore General... and other collaborators

Completed

Adult Dengue Platelet Study (ADEPT)

Dengue Fever

Malaysia, Singapore
Singapore General Hospital

Active, not recruiting

Prospective Registry to Investigate the Safety and Efficacy of the Treatment With the Selution Sirolimus Drug Coated Balloon in TASC C and D Atheroma-occlusive Infra-Inguinal Disease in Patients With Chronic Limb Threatening Ischemia From Singapore (PRISTINE)

Peripheral Artery Disease | Critical Lower Limb Ischemia

Singapore
Singapore General Hospital
Duke-NUS Graduate Medical School

Completed

Modulate Cellular Stress in the Immune Cells to Reduce Rate of Symptomatic Viral Infection

Yellow Fever | Viral Infection | Endoplasmic Reticulum Stress

Singapore
National Heart Centre Singapore
Agency for Science, Technology and Research

Recruiting

AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry (APOLLO)

Coronary Artery Disease | Coronary Stenosis | CAD | Plaques; Epicardial

Singapore
Changi General Hospital

Terminated

Procalcitonin in Fever of Unknown Etiology

Fever

Singapore
AbbVie

Active, not recruiting

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) (KEEPsAKE2)

Psoriatic Arthritis (PsA)

United States, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Netherlands, New Zealand, Poland, Portugal, Puerto Rico, Singapore, South Africa, Spain, Sweden, United...
Singapore General Hospital
Duke-NUS Graduate Medical School

Recruiting

An Experimental Medicine Decipher of a Minimum Correlate of Cellular Immunity

Japanese Encephalitis | Infectious Disease | Yellow Fever | Viral Infection

Singapore
Novartis Pharmaceuticals

Completed

Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis (FUTURE 1 ext)

Psoriatic Arthritis

United Kingdom, Belgium, Germany, Thailand, Israel, United States, Philippines, Singapore, Italy, Argentina, Russian Federation, Bulgaria, Czechia, Australia, Canada, Poland, Brazil, Slovakia
Novartis Pharmaceuticals

Completed

Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA) (FUTURE 1)

Psoriatic Arthritis

Germany, United Kingdom, United States, Belgium, Philippines, Singapore, Thailand, Brazil, Czech Republic, Italy, Argentina, Israel, Russian Federation, Bulgaria, Romania, Australia, Canada, Poland, Slovakia
National Environment Agency, Singapore
Ministry of Health, Singapore

Recruiting

Impact of Project Wolbachia - Singapore on Dengue Incidence

Dengue

Singapore
SingHealth Polyclinics

Completed

Effects of a Serious Game on Knowledge, Attitude and Practice in Vector Control and Dengue Prevention Among Adults in Primary Care

Dengue

Singapore
AbbVie

Active, not recruiting

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (KEEPsAKE 1)

Psoriatic Arthritis

United States, Argentina, Australia, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, Croatia, Czechia, Denmark, Estonia, Finland, Germany, Greece, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico and more
Boehringer Ingelheim

Completed

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

Generalized Pustular Psoriasis

United States, Singapore, Korea, Republic of, Germany, Japan, Malaysia, China, France, Thailand, Tunisia, Switzerland, Taiwan
Galderma R&D

Completed

Efficacy & Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
Novartis Pharmaceuticals

Recruiting

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

Dengue

Singapore, Malaysia, India
AbbVie

Active, not recruiting

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) (SELECT - PsA 1)

Psoriatic Arthritis

United States, Argentina, Australia, Belarus, Belgium, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czechia, Estonia, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic... and more
Boehringer Ingelheim

Recruiting

A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares

Generalized Pustular Psoriasis

Korea, Republic of, Australia, Italy, Spain, Belgium, China, Malaysia, Singapore, United States, Turkey, Taiwan, Germany, France, Tunisia, Brazil, Thailand, India, South Africa
Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Yellow Fever

Germany, France, Finland, Singapore, Spain, Thailand
Galderma R&D

Active, not recruiting

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

Moderate-to-Severe Atopic Dermatitis

United States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
National Institute of Allergy and Infectious Diseases...
University of Oxford; Wellcome Trust; World Health Organization

Completed

High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

Influenza | Avian Influenza | Severe Influenza

Singapore, Thailand, Vietnam
Takeda

Completed

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Healthy

Colombia, Singapore, Thailand, Puerto Rico

Clinical Trials on Moderate and Severe Plaque Psoriasis in Singapore

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations